Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Xylooligosaccharides from hardwood and cereal xylans produced by a thermostable xylanase as carbon sources for Lactobacillus brevis and Bifidobacterium adolescentis. β
Go to Publication β
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 61 Issue 30 Pages: 7333-40 Pub: 2013 Jul 31 Epub: 2013 Jul 23 Authors Falck P , Precha-Atsawanan S , Grey C , Immerzeel P , Stålbrand H , Adlercreutz P , Karlsson EN , |
|
|
Supplemental Xylooligosaccharide Modulates Intestinal Mucosal Barrier and Cecal Microbiota in Laying Hens Fed Oxidized Fish Oil. β
Go to Publication β
Frontiers in microbiology (Front Microbiol ) Vol: 12 Issue Pages: 635333 Pub: 2021 Epub: 2021 Feb 22 Authors Zhou JM , Zhang HJ , Wu SG , Qiu K , Fu Y , Qi GH , Wang J , |
|
|
Chronic oral exposure to glycated whey proteins increases survival of aged male NOD mice with autoimmune prostatitis by regulating the gut microbiome and anti-inflammatory responses. β
Go to Publication β
Food & function (Food Funct ) Vol: 11 Issue 1 Pages: 153-162 Pub: 2020 Jan 29 Epub: Authors Chen Y , Guo KM , Nagy T , Guo TL , |
|
|
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium. β
Go to Publication β
Food science & nutrition (Food Sci Nutr ) Vol: 12 Issue 2 Pages: 1119-1132 Pub: 2024 Feb Epub: 2023 Nov 27 Authors Yi W , Wang Q , Xue Y , Cao H , Zhuang R , Li D , Yan J , Yang J , Xia Y , Zhang F , |
|
|
Dose-Dependent Effects of Dietary Xylooligosaccharides Supplementation on Microbiota, Fermentation and Metabolism in Healthy Adult Cats. β
Go to Publication β
Molecules (Basel, Switzerland) (Molecules ) Vol: 25 Issue 21 Pages: Pub: 2020 Oct 29 Epub: 2020 Oct 29 Authors Lyu Y , Debevere S , Bourgeois H , Ran M , Broeckx BJG , Vanhaecke L , Wiele TV , Hesta M , |
|
|
Oligosaccharide and Flavanoid Mediated Prebiotic Interventions to Treat Gut Dysbiosis Associated Cognitive Decline. β
Go to Publication β
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (J Neuroimmune Pharmacol ) Vol: 17 Issue 1-2 Pages: 94-110 Pub: 2022 Jun Epub: 2022 Jan 19 Authors Sarkar SR , Mazumder PM , Banerjee S , |
|
|
Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 778542 Pub: 2021 Epub: 2021 Dec 28 Authors Li Z , Li Z , Zhu L , Dai N , Sun G , Peng L , Wang X , Yang Y , |
|
|
Dietary supplementation with low-dose xylooligosaccharide promotes the anti-Salmonella activity of probiotic Lactiplantibacillus plantarum ZS2058 in a murine model. β
Go to Publication β
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 151 Issue Pages: 110858 Pub: 2022 Jan Epub: 2021 Dec 6 Authors Liu J , Li X , Song F , Cui S , Lu W , Zhao J , Zhang H , Gu Z , Chen W , |
|
|
Effect of Lacticaseibacillus paracasei K56 with galactooligosaccharide synbiotics on obese individuals: an in vitro fermentation model. β
Go to Publication β
Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 104 Issue 9 Pages: 5042-5051 Pub: 2024 Jul Epub: 2024 Feb 20 Authors Zhang Q , Zhao W , He J , He J , Shi S , Sun M , Niu X , Zeng Z , Zhao Y , Zhang Y , Wang P , Li Y , Zhang C , Duan S , Hung WL , Wang R , |
|
|
Research Note: Effect of dietary xylo-oligosaccharide on growth performance, intestinal histomorphology, and specific cecal bacteria in broiler chickens. β
Go to Publication β
Poultry science (Poult Sci ) Vol: 103 Issue 1 Pages: 103189 Pub: 2024 Jan Epub: 2023 Oct 17 Authors Yadav S , Singh AK , Selvaraj RK , Applegate TJ , Bhattacharya P , Shinall SB , Fenn LS , Shanmugasundaram R , Kim WK , |
|
|
Similarities and differences of oligo/poly-saccharides' impact on human fecal microbiota identified by in vitro fermentation. β
Go to Publication β
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 105 Issue 19 Pages: 7475-7486 Pub: 2021 Oct Epub: 2021 Sep 6 Authors Wang S , Zhang X , Li H , Ren Y , Geng Y , Lu Z , Shi J , Xu Z , |
|
|
In vitro fermentability of xylo-oligosaccharide and xylo-polysaccharide fractions with different molecular weights by human faecal bacteria. β
Go to Publication β
Carbohydrate polymers (Carbohydr Polym ) Vol: 179 Issue Pages: 50-58 Pub: 2018 Jan 1 Epub: 2017 Sep 6 Authors Ho AL , Kosik O , Lovegrove A , Charalampopoulos D , Rastall RA , |
|
|
In vitro study of the prebiotic xylooligosaccharide (XOS) on the growth of Bifidobacterium spp and Lactobacillus spp. β
Go to Publication β
International journal of food sciences and nutrition (Int J Food Sci Nutr ) Vol: 66 Issue 8 Pages: 919-22 Pub: 2015 Epub: 2015 Jul 14 Authors Li Z , Summanen PH , Komoriya T , Finegold SM , |
|
|
Dietary xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats. β
Go to Publication β
BMC research notes (BMC Res Notes ) Vol: 7 Issue Pages: 660 Pub: 2014 Sep 19 Epub: 2014 Sep 19 Authors Christensen EG , Licht TR , Leser TD , Bahl MI , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
